Invesaro

Stocks Comparison

AbbVie vs ELI LILLY: revenue, profit, margins and growth compared

AbbVie brought in $61.2B of revenue in fiscal 2025, ELI LILLY $65.2B in fiscal 2025. Revenue changed by +8.6% at AbbVie and +44.7% at ELI LILLY on the year before, so ELI LILLY grew faster. AbbVie kept 6.9% of its revenue as net profit, ELI LILLY 31.7%.

Open the ABBV pageOpen the LLY page

Side by side, latest fiscal year

ABBVLLY
Fiscal year endedFY2025 (December 31, 2025)FY2025 (December 31, 2025)
Revenue$61.2B$65.2B
Revenue growth+8.6%+44.7%
Net income$4.2B$20.6B
Net margin6.9%31.7%
Free cash flow$17.8Bn/a
Free cash flow margin29.1%n/a
Earnings per share (diluted)$2.36$22.95
Cash$5.2B$7.3B
Debt$64.5B$40.9B
Price to earnings112.051.6
Market value$467.1B$1.11T
Dividend yield2.52%0.53%
Rank by revenue in sector#14 of 523 · Health care#11 of 523 · Health care

Over the years

Revenue
ABBV FY2018: $32.8BABBV FY2019: $33.3BABBV FY2020: $45.8BABBV FY2021: $56.2BABBV FY2022: $58.1BABBV FY2023: $54.3BABBV FY2024: $56.3BABBV FY2025: $61.2BLLY FY2018: $21.5BLLY FY2019: $22.3BLLY FY2020: $24.5BLLY FY2021: $28.3BLLY FY2022: $28.5BLLY FY2023: $34.1BLLY FY2024: $45BLLY FY2025: $65.2BFY18FY19FY20FY21FY22FY23FY24FY25
ABBV $61.2BLLY $65.2B
Net income
ABBV FY2018: $5.7BABBV FY2019: $7.9BABBV FY2020: $4.6BABBV FY2021: $11.5BABBV FY2022: $11.8BABBV FY2023: $4.9BABBV FY2024: $4.3BABBV FY2025: $4.2BLLY FY2018: $3.2BLLY FY2019: $8.3BLLY FY2020: $6.2BLLY FY2021: $5.6BLLY FY2022: $6.2BLLY FY2023: $5.2BLLY FY2024: $10.6BLLY FY2025: $20.6BFY18FY19FY20FY21FY22FY23FY24FY25
ABBV $4.2BLLY $20.6B
Net margin
ABBV FY2018: 17.4%ABBV FY2019: 23.7%ABBV FY2020: 10.1%ABBV FY2021: 20.5%ABBV FY2022: 20.4%ABBV FY2023: 9.0%ABBV FY2024: 7.6%ABBV FY2025: 6.9%LLY FY2018: 15.0%LLY FY2019: 37.3%LLY FY2020: 25.2%LLY FY2021: 19.7%LLY FY2022: 21.9%LLY FY2023: 15.4%LLY FY2024: 23.5%LLY FY2025: 31.7%FY18FY19FY20FY21FY22FY23FY24FY25
ABBV 6.9%LLY 31.7%
Revenue growth
ABBV FY2019: +1.6%ABBV FY2020: +37.7%ABBV FY2021: +22.7%ABBV FY2022: +3.3%ABBV FY2023: -6.4%ABBV FY2024: +3.7%ABBV FY2025: +8.6%LLY FY2019: +3.8%LLY FY2020: +9.9%LLY FY2021: +15.4%LLY FY2022: +0.8%LLY FY2023: +19.6%LLY FY2024: +32.0%LLY FY2025: +44.7%FY19FY20FY21FY22FY23FY24FY25
ABBV +8.6%LLY +44.7%
Free cash flow
ABBV FY2018: $12.8BABBV FY2019: $12.8BABBV FY2020: $16.8BABBV FY2021: $22BABBV FY2022: $24.2BABBV FY2023: $22.1BABBV FY2024: $17.8BABBV FY2025: $17.8BFY18FY19FY20FY21FY22FY23FY24FY25
ABBV $17.8BLLY

Fiscal years as each company reports them; the two may end in different months.

Questions about AbbVie and ELI LILLY

Which is bigger by revenue, AbbVie or ELI LILLY?

ELI LILLY is bigger by revenue: $65.2B in fiscal 2025, against $61.2B for AbbVie in fiscal 2025.

Which keeps more of its revenue as profit, AbbVie or ELI LILLY?

AbbVie had a net margin of 6.9% in fiscal 2025; ELI LILLY had 31.7% in fiscal 2025.

Which grew revenue faster, AbbVie or ELI LILLY?

In their latest fiscal years revenue changed by +8.6% at AbbVie and +44.7% at ELI LILLY.

Where do these numbers come from?

From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.

More comparisons

ABBV vs JNJ
ABBV vs MRK
ABBV vs PFE
JNJ vs LLY
LLY vs MRK
LLY vs PFE

Compare more companies